> Where vaccine availability is low, its not due to US hoarding but rather due to regional government policy constraints that wouldn't be alleviated if this-US-kid gave up their dose.

Pharmaceutical companies would invest more in finding ways around regional constraints if they didn't have a free profit square by selling their vaccines in the US.